Depression
CBD and Depression: Articles, Research and Scientific Studies
Articles About CBD and Depression
World Class Athletes, U.S. Vets And The
Woodstock Generation Are Igniting A Pain-Management Revolution Using CBD Rich Hemp Oil
Who Needs Pain-Management? Athletes are always in some degree of pain, either from training for competition or from actually competing. That’s why pain-management is vital for the long-term success of the pros. Fortunately for top athletes, the World Anti-Doping Agency (WADA) has this year removed THC-free Cannabidiol, CBD, from its list of banned substances. It’s... Continue
The Father of Medical Marijuana Would Be Shocked to Learn This
The Father of Medical Marijuana, Dr. Roger Adams (1889-1971), would be shocked and amazed to learn what’s happening with cannabis these days. Dr. Adams was awarded U.S. Patent #2,304,669 for isolating the medical component of cannabis, now known as CBD, or Cannabidiol (pronounced can-na-bi-DIAL). He applied for the patent on August 16, 1940. It was... Continue
CBD Research and Depression
- Endocannabinoid system dysfunction in mood and related disorders
- Antidepressant-Like and Anxiolytic-Like Effects of CBD
- The endocannabinoid system and the treatment of mood and anxiety disorders
- Endocannabinoid signaling in the etiology and treatment of major depressive illness
- Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors
- Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants
- Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa
- Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
- Serum contents of endocannabinoids are correlated with blood pressure in depressed women
- The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants
- Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures
